Biodegradable poly(α-hydroxy acid) polymer scaffolds for bone tissue engineering

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 93, Issue 1, 2010, Pages 285-295

  Yu, Nicole Y C ^a,b   Schindeler, Aaron ^b,c   Little, David G ^b,c   Ruys, Andrew J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c University of Sydney   (Australia)

Author keywords

Biodegradable; Bone tissue engineering; Poly D,L lactide; Polymer; Scaffold

Indexed keywords

AUTOGENOUS BONE; BONE ALLOGRAFTS; BONE DEFECT; BONE MORPHOGENETIC PROTEINS; BONE TISSUE ENGINEERING; D , L-LACTIDE; DESIGN PARAMETERS; FABRICATION TECHNIQUE; HYDROXY ACIDS; OSTEOCONDUCTIVE; OSTEOGENIC; POLYMER SCAFFOLDS; SYNTHETIC GRAFTS;

ACIDS; BIODEGRADABLE POLYMERS; BIODEGRADATION; BONE; CARBOXYLIC ACIDS; GRAFTING (CHEMICAL); POLYMERS; PROTEINS; SCAFFOLDS;

TISSUE ENGINEERING;

BONE MORPHOGENETIC PROTEIN; CALCIUM PHOSPHATE; MICROSPHERE; POLY ALPHA HYDROXYACID POLYMER; POLYGLYCOLIDE; POLYLACTIDE; POLYMER; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

BIOCOMPATIBILITY; BIODEGRADABILITY; BONE DEVELOPMENT; BONE TISSUE; CAST APPLICATION; CERAMIC PROSTHESIS; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; COMPOSITE MATERIAL; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; EMULSION; FOAMING; FREEZE DRYING; IN VIVO STUDY; LEACHING; MATERIALS TESTING; MOLECULAR WEIGHT; PH; PHASE TRANSITION; POLYMERIZATION; POROSITY; REVIEW; SURFACE PROPERTY; TISSUE ENGINEERING;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE SUBSTITUTES; DRUG DELIVERY SYSTEMS; HYDROXY ACIDS; MATERIALS TESTING; MICROSPHERES; OSTEOGENESIS; POLYMERS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77949505276     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31588     Document Type: Review

References (136)

1. Hui JHP, Ouyang HW, Hutmacher DW, Goh JCH, Lee EH. Mesenchymal stem cells in musculoskeletal tissue engineering: A review of recent advances in National University of Singapore. Ann Acad Med Singapore 2005;34:206-212.
2. Laurencin CT, Ambrosio AMA, Borden MD, Cooper JA. Tissue engineering: Orthopedic applications. Annu Rev Biomed Eng 1999;1:19-46.
3. Celil AB, Guelcher S, Hollinger JO, Miller M. Tissue engineering applications: Bone. In: Bronzino JD, editor. Tissue Engineering and Artificial Organs. Boca Raton, Florida: Taylor & Francis Group, LLC; 2006.
4. Salgado AJ, Coutinho OP, Reis RL. Bone tissue engineering: State of the art and future trends. Macromol Biosci 2004;4:743-765.
5. Russell JL, Block JE. Surgical harvesting of bone graft from the ilium: Point of view. Med Hypotheses 2000;55:474-479.
6. Yoshikawa H, Myoui A. Bone tissue engineering with porous hydroxyapatite ceramics. J Artif Organs 2005;8:131-136.
7. Giannoudis PV, Einhorn TA, Marsh D. Fracture healing: The diamond concept. Injury 2007;38 (Suppl 4):S3-S6.
8. Burg K, Porter S, Kellam J. Biomaterial developments for bone tissue engineering. Biomaterials 2000;21:2347-2359.
9. Stevens M. Biomaterials for bone tissue engineering. Mat Today 2008;11:18-25.
10. Barry FP, Murphy JM. Mesenchymal stem cells: Clinical applications and biological characterization. Int J Biochem Cell Biol 2004;36:568.
11. Polak JM, Bishop AE. Stem cells and tissue engineering: Past, present, and future. Ann N Y Acad Sci 2006;1068:352-366.
12. Dimitriou R, Giannoudis PV. Discovery and development of BMPs. Injury 2005;36(3S1):S28-S33.
13. Geesink RGT, Hoefnagels NHM, Bulstra SK. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br 1999;81B:710-718.
14. Govender SM, Csimma CRM, Genant HKM, Valentin-Opran AM. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002;84A:2123-2134.
15. Kato M, Toyoda H, Namikawa T, Hoshino M, Terai H, Miyamoto S, Takaoka K. Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2). Biomaterials 2006;27:2035-2041.
16. McKay W, Peckham S, Badura J. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSEV® Bone Graft). Int Orthop 2007;31:729-734.
17. Reddi AH. Symbiosis of biotechnology and biomaterials: Applications in tissue engineering of bone and cartilage. J Cell Biochem 1994;56:192-195.
18. Ripamonti U, Hari Reddi A. Tissue engineering, morphogenesis, and regeneration of the periodontal tissues by bone morphogenetic proteins. Crit Rev Oral Biol Med 1997;8:154-163.
19. White A, Vaccaro A, Hall J, Whang P, Friel B, McKee M. Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion. Int Orthop 2007;31:735-741.
20. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone 1992;13:81-88.
21. Termaat MF, Den Boer FC, Bakker FC, Patka P, Haarman HJTM. Bone morphogenetic proteins: Development and clinical efficacy in the treatment of fractures and bone defects. J Bone Joint Surg Am 2005;87:1367-1378.
22. Zapf J, Hauri C, Waldvogel M, Froesch ER. Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. J Clin Invest 1986;77:1768-1775.
23. Zioncheck TF, Chen SA, Richardson L, Mora-Worms M, Lucas C, Lewis D, Green JD, Mordenti J. Pharmacokinetics and tissue distribution of recombinant human transforming growth factor beta1 after topical and intravenous administration in male rats. Pharm Res 1994;11:213-220.
24. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual drug growth factor delivery. Nat Biol 2001;19:1029-1034.
25. Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, Higashio K, Quinn JMW, Gillespie MT, Martin TJ, Suda T, Takahashi N. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-jB Ligand. Endocrinology 2001;142:3656-3662.
26. Kaneko H, Arakawa T, Mano H, Kaneda T, Ogasawara A, Nakagawa M, Toyama Y, Yabe Y, Kumegawa M, Hakeda Y. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone 2000;27:479-486.
27. Saito N, Takaoka K. New synthetic biodegradable polymers as BMP carriers for bone tissue engineering. Biomaterials 2003;24:2287-2293.
28. Gonda K, Nakaoka T, Yoshimura K, Otawara-Hamamoto Y, Harrii K. Heterotopic ossification of degenerating rat skeletal muscle induced by adenovirus-mediated transfer of bone morphogenetic protein-2 gene. J Bone Miner Res 2000;15:1056-1065.
29. Zhang X, Xie C, Lin ASP, Ito H, Awad H, Lieberman JR, Rubery PT, Schwarz EM, O'Keefe RJ, Guldberg RE. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: Implications for functional tissue engineering. J Bone Miner Res 2005;20:2124-2137.
30. Geesink RGT, Hoefnagels NHM, Bulstra SK. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg 1999;81:710-718.
31. Olsen D, Yang C, Bodo M, Chang R, Leigh S, Baez J, Carmichael D, Perälä M, Hämäläinen E, Jarvinen M, Polavek J. Recombinant collagen and gelatin for drug delivery. Adv Drug Deliv Rev 2003;55:1547.
32. DeLustro F, Dasch J, Keefe J, Ellingsworth L. Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clin Orthop Relat Res 1990;260:263-279.
33. Blaker JJ, Gough JE, Maquet V, Notingher I, Boccaccini AR. In vitro evaluation of novel bioactive composites based on bioglass-filled polylactide foams for bone tissue engineering scaffolds. J Biomed Mater Res A 2003;67A:1401-1411.
34. Matsushita N, Terai H, Okada T, Nozaki K, Inoue H, Miyamoto S, Takaoka K. A new bone-inducing biodegradable porous beta-tricalcium phosphate. J Biomed Mater Res A 2004;70A:450-458.
35. Murakami N, Saito N, Horiuchi H, Okada T, Nozaki K, Takaoka K. Repair of segmental defects in rabbit humeri with titanium fiber mesh cylinders containing recombinant human bone morphogenetic protein-2 (rhBMP-2) and a synthetic polymer. J Biomed Mater Res 2002;62:169-174.
36. Saito N, Okada T, Horiuchi H, Murakami N, Takahashi J, Nawata M. Biodegradable poly-D,L-lactic acid-polyethylene glycol block copolymers as a BMP delivery system for inducing bone. J Bone Joint Surg Am 2001;83A:S92-S98.
37. Thompson H. Biomaterials: We Have the Technology. Medical Device & Diagnostic Industry; 2005. Available at: http://www.devicelink. com/mddi/archive/0505/024.html. Accessed June 9th 2009.
38. Liu X, Ma PX. Polymeric scaffolds for bone tissue engineering. Ann Biomed Eng 2004;32:477-486.
39. Jagur-Grodzinski J. Polymers for tissue engineering, medical devices, and regenerative medicine. Concise general review of recent studies. Polym Adv Technol 2006;17:395-418.
40. Sokolsky-Papkov M, Agashi K, Olaye A, Shakesheff K, Domb AJ. Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Res 2007;59:187-206.
41. Katti DS, Lakshmi S, Langer R, Laurencin CT. Toxicity, biodegradation and elimination of polyanhydrides. Adv Drug Deliv Rev 2002;54:933-961.
42. Nair LS, Laurencin CT. Biodegradable polymers as biomaterials. Prog Polym Sci 2007;32:762-798.
43. Tsuruga E, Takita H, Itoh H, Wakisaka Y, Kuboki Y. Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. J Biochem 1997;121:317-324.
44. Sokolsky-Papkov M, Agashi K, Olaye A, Shakesheff K, Domb AJ. Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007;59:187-206.
45. Maurus PB, Kaeding CC. Bioabsorbable implant material review. Oper Tech Sports Med 2004;12:158-160.
46. Leinonen S, Suokas E, Veiranto M, Törmälä P, Waris T, Ashammakhi N. Holding power of bioabsorbable ciprofloxacin-containing self-reinforced poly-L/DL-lactide 70/30 bioactive glass 13 miniscrews in human cadaver bone. J Craniofac Surg 2002;13:212-218.
47. Middleton JC, Tipton AJ. Synthetic biodegradable polymers as orthopedic devices. Biomaterials 2000;21:2335-2346.
48. Saito N, Murakami N, Takahashi J, Horiuchi H, Ota H, Kato H, Okada T, Nozaki K, Takaoka K. Synthetic biodegradable polymers as drug delivery systems for bone morphogenetic proteins. Adv Drug Deliv Rev 2005;57:1037-1048.
49. Yoon DM, Fisher JP. Polymeric scaffolds for tissue engineering applications. In: Bronzino JD, editor. Tissue Engineering and Artificial Organs (The Biomedical Engineering Handbook). Boca Raton, FL: CRC Press/Taylor & Francis; 2006. pp 1-12.
50. Mooney DJ, Baldwin DF, Suh NP, Vacanti JP, Langer R. Novel approach to fabricate porous sponges of poly(lactic-co-glycolic acid) without the use of organic solvents. Biomaterials 1996;17:1417-1422.
51. Hollister SJ. Porous scaffold design for tissue engineering. Nat Mater 2005;4:518-524.
52. Mikos AG, Thorsen AJ, Czerwonka LA, Bao Y, Langer R, Winslow DN, Vacanti JP. Preparation and characterization of poly(L-lactic acid) foams. Polymer 1994;35:1068-1077.
53. Mooney DJ, Kaufmann PM, Sano K, McNamara KM, Vacanti JP, Langer R. Transplantation of hepatocytes using porous, biodegradable sponges. Transplant Proc 1994;26:3425-3426.
54. Seeherman H, Wozney JM. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 2005;16:329-345.
55. Lo H, Ponticiello MS, Leong KW. Fabrication of controlled release biodegradable foams by phase separation. Tissue Eng 1995;1:15-28.
56. Bruder SPMDP, Fox BSP. Tissue engineering of bone: Cell based strategies. Clin Orthop Relat Res 1999;367:S68-S83.
57. Saito N, Okada T, Horiuchi H, Murakami N, Takahashi J, Nawata M, Ota H, Nozaki K, Takaoka K. A biodegradable polymer as a cytokine delivery system for inducing bone formation. Nat Biotechnol 2001;19:332-335.
58. Whang K, Thomas C, Healy K, Nuber G. A novel method to fabricate bioabsorbable scaffolds. Polymer 1995;36:837-842.
59. Whang K, Tsai D, Nam E, Aitken M, Sprague S, Patel P, Healy K. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds. J Biomed Mater Res 1998;42:491-499.
60. Nam YS, Park TG. Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation. J Biomed Mater Res A 1999;47:8-17.
61. Dalton P, Woodfield T, Hutmacher DW. Snapshot: Polymer scaffolds for tissue engineering. Biomaterials 2009;30:701-702.
62. Schliephake H, Weich H, Dullin C, Gruber R, Frahse S. Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid: An experimental study in rats. Biomaterials 2008;29:103-110.
63. Schliephake H, Weich H, Schulz J, Gruber R. In vitro characterization of a slow release system of polylactic acid and rhBMP2. J Biomed Mater Res A 2007;83A:455-462.
64. Zhang P, Hong Z, Yu T, Chen X, Jing X. In vivo mineralization and osteogenesis of nanocomposite scaffold of poly(lactide-coglycolide) and hydroxyapatite surface-grafted with poly(L-lactide). Biomaterials 2009;30:58-70.
65. Nie H, Soh B, Fu Y-C, Wang C-H. Three-dimensional fibrous PLGA/HAp composite scaffold for BMP-2 delivery. Biotechnol Bioeng 2008;99:223-234.
66. Hu Y, Zhang C, Zhang S, Xiong Z, Xu J. Development of a porous poly(L-lactic acid)/hydroxyapatite/collagen scaffold as a BMP delivery system and its use in healing canine segmental bone defect. J Biomed Mater Res 2003;67A:591-598.
67. Yu D, Li Q, Mu X, Chang T, Xiong Z. Bone regeneration of critical calvarial defect in goat model by PLGA/TCP/rhBMP-2 scaffolds prepared by low-temperature rapid-prototyping technology. Int J Oral Maxillofac Surg 2008;37:929-934.
68. Ma P, Choi J-W. Biodegradable polymer scaffolds with well-defined interconnected spherical pore network. Tissue Eng 2001;7:23-33.
69. Burg KJL, Porter S, Kellam JF. Biomaterial developments for bone tissue engineering. Biomaterials 2000;21:2347-2359.
70. Liu X, Ma PX. Polymeric scaffolds for bone tissue engineering. Ann Biomed Eng 2004;32:477-486.
71. Sokolsky-Papkov M, Agashi K, Olaye A, Shakesheff K, Domb AJ. Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007;59:187-206.
72. Dalton P, Woodfield T, Hutmacher DW. Snapshot: Polymer scaffolds for tissue engineering. Biomaterials 2009;30:701-702.
73. Nam YS, Park TG. Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation. J Biomed Mater Res 1999;47:8-17.
74. 2 generated vascular endothelial growth factor encapsulated poly(DL-lactic acid) scaffolds induce angiogenesis in vitro. Biochem Biophys Res Commun 2007;352:135-141.
75. Harris LD, Kim B-S, Mooney DJ. Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res 1998;42:396-402.
76. Yang XB, Roach HI, Clarke NMP, Howdle SM, Quirk R, Shakesheff KM, Oreffo ROC. Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification. Bone 2001;29:523-531.
77. Park CB, Baldwin DF, Suh NP. Effect of the pressure drop rate on cell nucleation in continuous processing of microcellular polymers. Biomaterials 1995;35:432-440.
78. Biondi M, Ungaro F, Quaglia F, Netti PA. Controlled drug delivery in tissue engineering. Adv Drug Deliv Rev 2008;60:229-242.
79. Lu L, Stamatas GN, Mikos AG. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles. J Biomed Mater Res Part A 2000;50:440-451.
80. Peter SJ, Lu L, Kim DJ, Stamatas GN, Miller MJ, Yaszemski MJ, Mikos AG. Effects of transforming growth factor β-1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. J Biomed Mater Res 2000;50:452-462.
81. Elisseeff J, McIntosh W, Fu K, Blunk T, Langer R. Controlledrelease of IGF-I and TGF-β1 in a photopolymerizing hydrogel for cartilage tissue engineering. J Orthop Res 2001;19:1098-1104.
82. DeFail AJ, Chu CR, Izzo N, Marra KG. Controlled release of bioactive TGF-β1 from microspheres embedded within biodegradable hydrogels. Biomaterials 2006;27:1579-1585.
83. Kim S-S, Gwak S-J, Kim B-S. Orthotopic bone formation by implantation of apatite-coated poly(lactide-co-glycolide)/hydroxyapatite composite particulates and bone morphogenetic protein-2. J Biomed Mater Res Part A 2008;87A:245-253.
84. Borden M, Attawia M, Khan Y, El-Amin S, Laurencin C. Tissue-engineered bone formation in vivo using a novel sintered polymeric microsphere matrix. J Bone Joint Surg Br 2004;86B:1200-1208.
85. Boyan B, Lohmann C, Somers A, Niederauer G, Wozney J, Dean D Jr, Schwartz Z. Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo. J Biomed Mater Res 1999;46:51-59.
86. Yao J, Radin S, Leboy P, Ducheyne P. The effect of bioactive glass content on synthesis and bioactivity of composite poly (lactic -co-glycolic acid)/bioactive glass substrate for tissue engineering. Biomaterials 2005;26:1935-1943.
87. Lu HH, El-Amin SF, Scott KD, Laurencin CT. Three-dimensional, bioactive, biodegradable, polymer-bioactive glass composite scaffolds with improved mechanical properties support collagen synthesis and mineralization of human osteoblast-like cells in vitro. J Biomed Mater Res A 2003;64A:465-474.
88. DeFail AJ, Chu CR, Izzo N, Marra KG. Controlled release of bioactive TGF-β1 from microspheres embedded within biodegradable hydrogels. Biomaterials 2006;27:1579-1585.
89. Kim S-S, Gwak S-J, Kim B-S. Orthotopic bone formation by implantation of apatite-coated poly(lactide-co-glycolide)/hydroxyapatite composite particulates and bone morphogenetic protein-2. J biomed Mater Res A 2008;87A:245-253.
90. Kim S-S, Sun Park M, Jeon O, Yong Choi C, Kim B-S. Poly(lactide -co-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials 2006;27:1399-1409.
91. Anderson JM, Miller KM. Biomaterial biocompatibility and the macrophage. Biomaterials 1984;5:5-10.
92. Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997;28:5-24.
93. Yoon SJ, Kim SH, Ha HJ, Ko YK, So JW, Kim MS, Yang YI, Khang G, Rhee JM, Lee HB. Reduction of inflammatory reaction of poly(D,L-lactic -co-glycolic acid) using demineralized bone particles. Tissue Eng Part A 2008;14:539-547.
94. Calandrelli L, Immirzi B, Malinconico M, Orsello G, Volpe M, Della Ragione F, Zappia V, Oliva A. Biocompatibility studies on biodegradable polyester-based composites of human osteoblasts: A preliminary screening. J Biomed Mater Res 2002;59:611-617.
95. Calandrelli L, Immirzi B, Malinconico M, Volpe MG, Oliva A, Della Ragione F. Preparation and characterization of composites based on biodegradable polymers for in vivo application. Polymer 2000;41:8027.
96. Day RM, Maquet V, Boccaccini AR, Jérôme R, Forbes A. In vitro and in vivo analysis of macroporous biodegradable poly(D,L-lactide-co-glycolide) scaffolds containing bioactive glass. J Biomed Mater Res A 2005;75:778.
97. Liu A, Hong Z, Zhuang X, Chen X, Cui Y, Liu Y, Jing X. Surface modification of bioactive glass nanoparticles and the mechanical and biological properties of poly(L-lactide) composites. Acta Biomater 2008;4:1005-1015.
98. Maquet V, Boccaccini AR, Pravata L, Notingher I, Jé rôme R. Preparation, characterization, and in vitro degradation of bioresorbable and bioactive composites based on BioglassVR -filled polylactide foams. J Biomed Mater Res A 2003;66A:335-346.
99. Maquet V, Boccaccini AR, Pravata L, Notingher I, Jérôme R. Porous poly(α-hydroxyacid)/BioglassV® composite scaffolds for bone tissue engineering. I: Preparation and in vitro characterization. Biomaterials 2004;25:4185-4194.
100. Dorozhkin S. Calcium orthophosphate-based biocomposites and hybrid biomaterials. J Mater Sci 2009;44:2343-2387.
101. Dorozhkin S. Calcium orthophosphates. J Mater Sci 2007;42:1061-1095.
102. Anselme K. Osteoblast adhesion on biomaterials. Biomaterials 2000;21:667-681.
103. Davies J. In vitro modeling of the bone/implant interface. Anat Rec 1996;245:426-445.
104. Dorozhkin S. Calcium orthophosphate cements for biomedical application. J Mater Sci 2008;43:3028-3057.
105. Hamanishi C, Kitamoto K, Ohura K, Tanaka S, Doi Y. Self-setting, bioactive, and biodegradable TTCP-DCPD apatite cement. J Biomed Mater Res 1996;32:383-389.
106. Kurashina K, Kurita H, Hirano M, Kotani A, Klein C, de Groot K. In vivo study of calcium phosphate cements: Implantation of an a-tricalcium phosphate/dicalcium phosphate dibasic/tetracalcium phosphate monoxide cement paste. Biomaterials 1997;18:539-543.
107. Mirtchi A, Lemaitre J, Munting E. Calcium phosphate cements: Study of the b-tricalcium phosphate-dicalcium phosphate-calcite cements. Biomaterials 1990;11:83-88.
108. Takagi S, Chow L, Ishikawa K. Formation of hydroxyapatite in new calcium phosphate cements. Biomaterials 1998;19:1593-1599.
109. Metsger D, Driskell T, Paulsrud J. Tricalcium phosphate ceramic: A resorbable bone implant: Review and current status. J Am Dent Assoc 1982;105:1035-1036.
110. Hench L. Bioceramics. J Am Ceram Soc 1998;81:1705-1728.
111. Suchanek W, Yoshimura M. Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implants. J Mater Res 1998;13:94-117.
112. Sun L, Berndt C, Gross K, Kucuk A. Material fundamentals and clinical performance of plasma-sprayed hydroxyapatite coatings: A review. J Biomed Mater Res 2001;58:570-592.
113. Bonfield W, Grynpas M, Tully A, Bowman J, Abram J. Hydroxyapatite reinforced polyethylene: A mechanically compatible implant material for bone replacement. Biomaterials 1981;2:85-186.
114. Jung Y, Kim S-S, Kim Y, Kim S-H, Kim B-S, Kim S, Choi C, Kim S. A poly(lactic acid)/calcium metaphosphate composite for bone tissue engineering. Biomaterials 2005;26:6314-6322.
115. Bonfield W. Composites for bone replacement. J Biomed Eng 1988;10:522-526.
116. Huang J, Silvio L, Wang M, Tanner K, Bonfield W. In vitro mechanical and biological assessment of hydroxyapatite-reinforced polyethylene composite. J Mater Sci Mater Med 1997;8:775-770.
117. Ladizesky N, Ward I, Bonfield W. Hydroxyapatite/high-performance polyethylene fiber composites for high-load-bearing bone replacement materials. J Appl Polym Sci 1997;65:1865-1882.
118. Causa F, Netti P, Ambrosio L, Ciapetti G, Baldini N, Pagani S, Martini D, Giunti A. Poly-e-caprolactone/hydroxyapatite composites for bone regeneration: In vitro characterization and human osteoblast response. J Biomed Mater Res 2006;76A:151-162.
119. Deng X, Hao J, Wang C. Preparation and mechanical properties of nanocomposites of poly(D,L-lactide) with Ca-deficient hydroxyapatite nanocrystals. Biomaterials 2001;22:2867-2873.
120. Juhasz J, Best S, Brooks R, Kawashita M, Miyata N, Kokubo T, Nakamura T, Bonfield W. Mechanical properties of glass-ceramic A-W-polyethylene composites: Effect of filler content and particle size. Biomaterials 2004;25:949-955.
121. Peter S, Miller S, Zhu G, Yasko A, Mikos A. In vivo degradation of a poly(propylene fumarate)/b-tricalcium phosphate injectable composite scaffold. J Biomed Mater Res 1998;41:1-7.
122. Kawanabe K, Yamamuro T, Nakamura T, Kotani S. Effects of injecting massive amounts of bioactive ceramics in mice. J Biomed Mater Res 1991;25:117-128.
123. Hench L, Splinter R, Allen W, Greenlee T. Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res 1971;5:117-141.
124. Radin S, Reilly G, Bhargave G, Leboy P, Ducheyne P. Osteogenic effects of bioactive glass on bone marrow stromal cells. J Biomed Mater Res 2005;73A:21-29.
125. Välimäki V, Yrjans J, Vuorio E, Aro H. Combined effect of BMP-2 gene transfer and bioactive glass microspheres on enhancement of new bone formation. J Biomed Mater Res 2005;75A:501-509.
126. Xynos I, Hukkanen M, Batten J, Buttery L, Hench L, Polak J. Bioglass ®45S5 stimulates osteoblast turnover and enhances bone formation in vitro: Implications and applications for bone tissue engineering. Calcif Tissue Int 2000;67:321-329.
127. Day RM, Boccaccini AR, Shurey S, Roether JA, Forbes A, Hench LL, Gabe SM. Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds. Biomaterials 2004; 25: 5857-5866.
128. Keshaw H, Forbes A, Day R. Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass. Biomaterials 2005;26:4171-4179.
129. Giannoudis P, Einhorn T, Schmidmaier G, Marsh D. The diamond concept: Open questions. Injury 2008;39 (Suppl 2):S5-S8.
130. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006;27:3413-3431.
131. Hollinger J, Battistone G. Biodegradable bone repair materials synthetic polymers and ceramics. Clin Orthop Relat Res 1986;207:290-230.
132. Jiang W, Gupta RK, Deshpande MC, Schwendeman SP. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable edlivery of vaccine antigens. Adv Drug Deliv Res 2005;57:391-410.
133. Saito N, Okada T, Toba S, Miyamoto S, Tanaka K. New synthetic absorbable polymers as BMP carriers: Plastic properties of poly-D,L-lactic acid-polyethylene glycol block copolymers. J Biomed Mater Res 1999;47:104-110.
134. Namikawa TMD, Terai HMDP, Suzuki EMDP, Hoshino MMD, Toyoda HMD, Nakamura HMDP, Miyamoto SMDP, Takahashi NP, Ninomiya TP, Takaoka KMDP. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and b-tricalcium phosphate in a rabbit model. Spine 2005;30:1717-1722.
135. Akamaru T, Suh D, Boden SD, Kim H-S, Minamide A, Louis-Ugbo J. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine funsion. Spine 2003;28:429-434.
136. Itoh HMD, Ebara SMD, Kamimura MMD, Tateiwa YMD, Kinoshita TMD, Yuzawa YMD, Takaoka KMD. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2. Spine 1999;24:1402-1405.